Uso de la trovafloxacina en el tratamiento de la neumonia adquirida en la comunidad
Luna, Carlos M; Gené, Ricardo J.
Medicina (B.Aires)
; 59(supl.1): 31-8, 1999. tab
Artículo en Español | LILACS, BINACIS | ID: lil-230472
Documentos relacionados
[Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children].
Ciprofloxacin-induced immune-mediated thrombocytopenia: No cross-reactivity with gemifloxacin.
When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases.
Mineralocorticoid Receptor Antagonists: a Comprehensive Review of Finerenone.
Pyronaridine: a review of its clinical pharmacology in the treatment of malaria.
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
[Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae].
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.
Trovafloxacin attenuates neuroinflammation and improves outcome after traumatic brain injury in mice.
[Finerenone: a new step on the way to nephroprotection].